|
WDR37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.10359999606314E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.81320000417429E-08 |
| Normal-vs-Stage2 |
3.153600E-02 |
| Normal-vs-Stage3 |
2.29149999997347E-06 |
| Normal-vs-Stage4 |
2.30629999999898E-05 |
| Stage1-vs-Stage2 |
2.311600E-01 |
| Stage1-vs-Stage3 |
3.355400E-01 |
| Stage1-vs-Stage4 |
3.369600E-01 |
| Stage2-vs-Stage3 |
9.260100E-02 |
| Stage2-vs-Stage4 |
1.115580E-01 |
| Stage3-vs-Stage4 |
7.482400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.59930005192177E-09 |
| Normal-vs-AfricanAmerican |
4.035400E-03 |
| Normal-vs-Asian |
4.726300E-02 |
| Caucasian-vs-AfricanAmerican |
5.862400E-02 |
| Caucasian-vs-Asian |
4.726200E-01 |
| AfricanAmerican-vs-Asian |
9.015000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.28920000125521E-08 |
| Normal-vs-Female |
4.181300E-03 |
| Male-vs-Female |
3.125900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.65169999999982E-05 |
| Normal-vs-Extreme_Weight |
8.30300050935762E-10 |
| Normal-vs-Obese |
3.66870000000352E-05 |
| Normal-vs-Extreme_Obese |
2.498400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.801200E-01 |
| Normal_Weight-vs-Obese |
4.604400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.112600E-01 |
| Extreme_Weight-vs-Obese |
2.623500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.383600E-01 |
| Obese-vs-Extreme_Obese |
5.456000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.500300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.40850000002391E-06 |
| Normal-vs-Age(61-80Yrs) |
2.4280999988413E-08 |
| Normal-vs-Age(81-100Yrs) |
9.10480000282377E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.582800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.135850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.661200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.828240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.938300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.275810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.60390000003563E-06 |
| Normal-VS-Type2 PRCC |
3.20819999455324E-08 |
| Normal-VS-KIRP CIMP |
3.960200E-02 |
| Normal-VS-Unclassified PRCC |
2.331700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.362800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.671600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.930100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.653600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.379600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.756800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.25919996651902E-09 |
| Normal-vs-N1 |
2.569600E-04 |
| Normal-vs-N2 |
5.411600E-04 |
| N0-vs-N1 |
8.670400E-01 |
| N0-vs-N2 |
3.987000E-01 |
| N1-vs-N2 |
5.323600E-01 |
|
|
